EUFLEX DIN 00637726
Health Canada record
| Active ingredient(s) | FLUTAMIDE 250 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L02BB01 FLUTAMIDE |
| Original market date | 31-Dec-1984 |
| Current status date | 01-Jun-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUTAMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02238560 | FLUTAMIDE | AA PHARMA INC | Tablet | FLUTAMIDE 250 MG | Marketed |
| 02230524 | DOM-FLUTAMIDE | DOMINION PHARMACAL | Tablet | FLUTAMIDE 250 MG | Cancelled Pre Market |
| 02230875 | FLUTAMIDE | PHARMASCIENCE INC | Tablet | FLUTAMIDE 250 MG | Cancelled Post Market |
| 02059673 | FLUTAMIDE | SCHERING-PLOUGH CANADA INC | Tablet | FLUTAMIDE 250 MG | Cancelled Post Market |
| 02239045 | FLUTAMIDE | PHARMEL INC | Tablet | FLUTAMIDE 250 MG | Cancelled Post Market |
| 02239388 | FLUTAMIDE-250 | PRO DOC LIMITEE | Tablet | FLUTAMIDE 250 MG | Cancelled Post Market |
| 02239082 | NU-FLUTAMIDE TABLETS | NU-PHARM INC | Tablet | FLUTAMIDE 250 MG | Cancelled (Unreturned Annual) |
| 02233019 | PENTA-FLUTAMIDE | PENTAPHARM LTD. | Tablet | FLUTAMIDE 250 MG | Cancelled (Unreturned Annual) |
| 02230104 | PMS-FLUTAMIDE | PHARMASCIENCE INC | Tablet | FLUTAMIDE 250 MG | Cancelled Post Market |
| 02230089 | TEVA-FLUTAMIDE | TEVA CANADA LIMITED | Tablet | FLUTAMIDE 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 12068 | 2011-02-15 | New Drug Submission (NDS) | Manufacturer name change |
International API supply for FLUTAMIDE
3 valid EDQM Certificates of Suitability from 3 holders. 2 active FDA Drug Master Files.
Request a quote for EUFLEX